Head-to-head comparison
Found vs Hims & Hers
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
The widest medication bench in the ranking — compounded, six brand-name products and oral orforglipron — priced off a membership rather than a sticker.
$289/mo sema · $289/mo tirz · Verified August 2026
Marked down on: The $99/mo headline is a longer-plan floor — Found's own FAQ says the 3, 6 and 12-month plans are what keep the monthly cost down, so month-to-month costs meaningfully more
Desk Score
Mass-market app-first program with nationwide polish — tirzepatide pricing disclosure lags the ranking.
$199/mo sema
Marked down on: Tirzepatide pricing inconsistently disclosed
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.
Found and Hims & Hers land level on the Desk Score at 79/100 — too close to call. The right choice comes down to which trade-offs fit your situation.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Found
79/100
C+
Hims & Hers
79/100
C+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Found | Hims & Hers |
|---|---|---|
| Semaglutide | $289/mo$289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); the advertised $99 is the in-network INSURANCE rate and still precedes a ~$30 per-visit copay | $199/mo$199/mo |
| Tirzepatide | $289/mo$289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); one program price covers both molecules | Not listed on Hims & Hers's site |
| Coverage | All 50 states | All 50 states |
| Brand-name | Yes | Compounded only |
| Oral option | Yes | Injectable only |
| Best for | People who want insurance run against their clinical visits and a clinician free to move them between compounded, brand-name and oral routes. | People who want a familiar consumer-brand app experience and don't need tirzepatide. |
| Desk Score | 79/100C+ | 79/100C+ |
The verdict
Too close to callFound and Hims & Hers land level on the Desk Score at 79/100 — too close to call. The right choice comes down to which trade-offs fit your situation.
Choose Found if…
People who want insurance run against their clinical visits and a clinician free to move them between compounded, brand-name and oral routes.
$289/mo sema · $289/mo tirz · All 50 states
Choose Hims & Hers if…
People who want a familiar consumer-brand app experience and don't need tirzepatide.
$199/mo sema · All 50 states
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Found · Hims & Hers.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Found
- CoreAge Rx vs Hims & Hers
- Found vs RxSpan MD
- Hims & Hers vs Ondra Health
- Curex vs Found
- Hims & Hers vs Vaylen
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.